| Management target | Revenue 14.0% |
|---|
| Revenue growth | 11.2% YoY |
|---|---|
| Margins | EBITDA margin improved from 6.0% to 8.2% YoY |
| Demand visibility | Strong institutional relationships in pharma and research |
| Management confidence | High regarding brand equity and 'Make in India' shift |
Growth
Consolidated EBITDA grew 50.1% YoY to Rs. 8.7 Cr; PAT turned positive to Rs. 4.4 Cr vs -4.2 Cr YoY.
Outlook
Targeting 12-14% Revenue CAGR; focus on expanding LabQuest and Process Sciences for higher margins and capacity utilization.
Risks
Lab Consumables revenue impacted by Ind AS 115; competition from imports and potential regulatory shifts in global markets.
Investor Presentation filed with BSE, NSE: BOROSCI. Summary written with AI assistance from the document.
Borosil Scientific Ltd: key numbers
- Share price
- ₹115.55
- Market cap
- ₹1,028 Cr
- Revenue (annual)
- ₹467.3 Cr
- Net profit (annual)
- ₹34.61 Cr
- P/E (TTM)
- 23.8×Sector 41.4×
- Promoter holding
- 68.27%+0.19% QoQ
- FII holding
- 0.23%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Borosil Scientific Ltd
All →Borosil Scientific Annual General Meeting
Borosil Scientific Limited held its 35th Annual General Meeting on September 25, 2026, via video conferencing to transact business stated in the notice.
Borosil Scientific Management Change
Mr. Kailash Motwani, Head of Operations at material subsidiary Pune & Goel Scientific Glass Works Limited, has resigned from his position as Senior Management Personnel.
Borosil Scientific Capacity Expansion: ₹60 Cr Investment
Borosil Scientific's board approved ₹60 Crore to build a new glassware plant in Bharuch. Capacity will expand from ~15 to ~108 lakhs units annually by March 2027.
- Value
- ₹60.00 Cr
- glassware production capacity addition
- 93 lakhs units per annum
Borosil Scientific Q1 FY27 Results: Turns Profitable, Net Profit ₹4.4 Cr
Borosil Scientific Ltd reported revenue from operations of ₹106.8 Cr (+11.2% YoY) and net profit of ₹4.4 Cr for Q1 FY27.
- Key figure
- Net profit ₹4.4 Cr
Borosil Scientific Earnings Call: Key Takeaways
Borosil Scientific delivered strong Q4FY26 results with Consolidated Net Sales up 10.6% and EBITDA up 87.6% YoY, driven by operational efficiency and scientific segment growth.
Borosil Scientific Q4 FY26 Results: Net Profit ₹27.2 Cr, Up 216.3% YoY
Borosil Scientific Ltd reported revenue from operations of ₹143.2 Cr (+10.6% YoY) and net profit of ₹27.2 Cr (+216.3% YoY) for Q4 FY26.
- Key figure
- Net profit ₹27.2 Cr · +216.3% YoY